Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunity-Reference-Cited by-同舟云学术

Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunity

Published:2022-05 Issue:5 Volume:55 Page:912-924.e8
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Maruhashi Takumi^ORCID,Sugiura Daisuke^ORCID,Okazaki Il-mi^ORCID,Shimizu Kenji,Maeda Takeo K.,Ikubo Jun,Yoshikawa Harunori,Maenaka Katsumi^ORCID,Ishimaru Naozumi,Kosako Hidetaka,Takemoto Tatsuya^ORCID,Okazaki Taku

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference38 articles.

1. The NOD mouse: a model of immune dysregulation;Anderson;Annu. Rev. Immunol.,2005

2. LAG3 (CD223) as a cancer immunotherapy target;Andrews;Immunol. Rev.,2017

3. Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups;Andrews;Nat. Immunol.,2019

4. Cutting edge: accelerated autoimmune diabetes in the absence of LAG-3;Bettini;J. Immunol.,2011

5. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection;Blackburn;Nat. Immunol.,2009

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking therapeutic potential: Targeting lymphocyte activation Gene-3 (LAG-3) with fibrinogen-like protein 1 (FGL1) in systemic lupus erythematosus;Journal of Translational Autoimmunity;2024-12

2. Screening, expression and anti-tumor functional identification of anti-LAG-3 nanobodies;Protein Expression and Purification;2024-10

3. Immune checkpoint inhibitors in infectious disease;Immunological Reviews;2024-09-09

4. Structural basis for mouse LAG3 interactions with the MHC class II molecule I-Ab;Nature Communications;2024-08-29

5. Exhaustion of T cells after renal transplantation;Frontiers in Immunology;2024-08-06